XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2016   10,793,946    
Beginning balance at Dec. 31, 2016 $ 172,521 $ 60,831 $ 111,693 $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,637   4,637  
Net unrealized gain on securities available for sale, net of tax 1     1
Net unrealized gain on cash flow hedging derivative instruments, net of tax 63     63
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (4)     (4)
Comprehensive income 4,697   4,637 60
Cash dividends declared (2,487)   (2,487)  
Equity compensation expense 83 $ 83    
Payment to repurchase of common stock (in shares)   (5,258)    
Payment to repurchase common stock $ (146)   (146)  
Issuance of restricted stock (in shares) 0 18,850    
Proceeds from sale of common stock (in shares)   6,594    
Proceeds from sale of common stock $ 185 $ 185    
Ending balance (in shares) at Mar. 31, 2017 10,814,132 10,814,132    
Ending balance at Mar. 31, 2017 $ 174,853 $ 61,099 113,697 57
Beginning balance (in shares) at Dec. 31, 2017 10,829,918 10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 121,144 (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,506   5,506  
Net unrealized gain on securities available for sale, net of tax (3,309)     (3,309)
Net unrealized gain on cash flow hedging derivative instruments, net of tax 384     384
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (8)     (8)
Comprehensive income 2,573   5,506 (2,933)
Cash dividends declared (2,607)   (2,607)  
Equity compensation expense 95 $ 95    
Payment to repurchase of common stock (in shares)   (5,725)    
Payment to repurchase common stock $ (167)   (167)  
Issuance of restricted stock (in shares) 0 16,795    
Proceeds from sale of common stock (in shares)   5,574    
Proceeds from sale of common stock $ 157 $ 157    
Ending balance (in shares) at Mar. 31, 2018 10,846,562 10,846,562    
Ending balance at Mar. 31, 2018 $ 181,372 $ 62,107 $ 123,876 $ (4,611)